The Latest Cardiac and Vascular News
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc., a leading developer of innovative devices for treating complex cardiovascular disease, announces the completion of enrollment in the DEEPER CORONARY study. This pilot study evaluates the Spur® Elute Coronary Sirolimus-Eluting Retrievable Scaffold System as a primary treatment for in-stent restenosis (ISR) of the coronary arteries […]
Data simultaneously published in The Journal of the American College of Cardiology (JACC) Results presented in late-breaking oral session showed danicamtiv was well tolerated with significant improvements in ventricular and atrial function in patients with genetic dilated cardiomyopathy (DCM) Data supports the planned investigation of danicamtiv in patients with familial […]
Santreva-ATK is the world’s first wire-free, external power-free, intraplaque chronic total occlusion (CTO) crossing and one-step vessel preparation platform for femoropopliteal arteries. – Atheroplasty represents a new era in endovascular revascularization of complex lesions in severely stenosed vessels, including CTOs – Now available in Europe; U.S. launch planned for October […]
– By Month 1, numerically fewer cumulative events were observed with acoramidis compared to placebo – Acoramidis significantly reduced the cumulative risk of CVM or recurrent CVH through Month 30 versus placebo with a 49% hazard reduction (p
$25 million investment to meet growing global demand for medical devices and precision components. Expansion to quadruple manufacturing footprint for high-volume minimally invasive catheters. Leveraging VR and AI for seamless tech transfers and optimized factory layouts. Grand Opening of Freudenberg Medical’s second operation in Costa Rica. Pictured: Keith Kiernan, Chief […]
AstraZeneca Direct is designed to offer greater convenience WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access their prescribed medications at a transparent cash price with home delivery. AstraZeneca Direct will support people living […]
Funding supports clinical trials of a minimally invasive therapy targeting a root cause of heart failure; co-founder Zoar Engelman, PhD, appointed CEO NEW YORK, Sept. 25, 2025 /PRNewswire/ — Axon Therapies, a clinical-stage medical device company pioneering a new approach to treating…
Data to be presented include two subgroup analyses from the pivotal Phase III FINEARTS-HF trial, which assessed the safety and efficacy of finerenone versus placebo in heart failure (HF) patients with left ventricular ejection fraction (LVEF) ≥40%. These analyses explored potential treatment effects in patients across a range of heart […]
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has entered a national partnership in the USA with Optum Healthcare. The inclusion of Philips’ Mobile Cardiac Telemetry (MCOT) and Philips Extended Holter (ePatch) in the network is designed to enable earlier detection of […]
By targeting the underlying drivers of disease with a pipeline of complementary candidates, Kardigan is building a platform that accelerates insights into core cardiovascular pathways to address multiple conditions where no treatments exist SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.–(BUSINESS WIRE)–Kardigan, a heart health company modernizing cardiovascular drug development, today […]
